Candel Therapeutics Inc (CADL)
6.72
-0.50
(-6.93%)
USD |
NASDAQ |
Jun 18, 16:00
6.72
0.00 (0.00%)
After-Hours: 07:55
Candel Therapeutics Cash and Short Term Investments (Quarterly): 25.71M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 25.71M |
| December 31, 2023 | 35.41M |
| September 30, 2023 | 42.98M |
| June 30, 2023 | 51.89M |
| March 31, 2023 | 59.26M |
| December 31, 2022 | 70.06M |
| September 30, 2022 | 77.18M |
| Date | Value |
|---|---|
| June 30, 2022 | 86.78M |
| March 31, 2022 | 94.32M |
| December 31, 2021 | 82.64M |
| September 30, 2021 | 88.38M |
| June 30, 2021 | 24.32M |
| March 31, 2021 | 29.15M |
| December 31, 2020 | 35.05M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
24.32M
Minimum
Jun 2021
94.32M
Maximum
Mar 2022
57.37M
Average
55.58M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Allurion Technologies Inc | 29.68M |
| AngioDynamics Inc | 78.45M |
| Eliem Therapeutics Inc | 105.03M |
| Macrogenics Inc | 184.24M |
| GlycoMimetics Inc | 31.28M |